Seeking Alpha

Transcept Pharmaceuticals (TSPT +6.8%) gets some follow-through off yesterday's +10% run, moving...

Transcept Pharmaceuticals (TSPT +6.8%) gets some follow-through off yesterday's +10% run, moving higher again today off the news that its sleep drug Intermezzo dodged an FDA bullet requiring a number of other sleep aids to reduce their dosage due to the risk of impaired cognitive function issues. The drug is the company's first FDA approved product.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)